View this email in your browser
26 million Americans
used marijuana in the past month 
In 2017, far more people age 12 and older used marijuana than any other drug.
That year there were 3 million new marijuana users, more than one-third (1.2 million) under age 18. Another third (1.3 million) were college-age young adults.
Worse, 8 percent of teens (250 thousand), 22 percent of young adults (2.6 million), and 20 percent of adults (5.3 million) used marijuana daily or near daily. During adolescence and young adulthood, the brain is still developing and at its most vulnerable to damage from frequent use of any addictive drug, including marijuana.
Today’s high-potency THC levels, some as high as 80 to 90 percent, were developed as a result of legalization. They concern the public-health community even more, given this escalation in daily use.
The 2017 National Survey on Drug Use and Health is an annual survey of some 67,500 people across the nation. It is funded by the Substance Abuse and Mental Health Services Administration of the U.S. Department of Health and Human Services. It collects data about the use of alcohol, tobacco, and illicit drugs and the misuse of prescription drugs among four age groups:
  • All—ages 12 and older
  • Youth—ages 12 to 17
  • Young Adults—ages 18 to 25
  • Adults—ages 26 and older
 Access the NSDUH here. Download infographic here.
Marijuana use up significantly
among young adults and adults
Past-month marijuana use increased among young adults and adults from 2015 to 2017.
  • Young adults
            19.8 percent (6.9 million people) in 2015
            22.1 percent (7.6 million people) in 2017 
  • Adults
            6.5 percent (13.6 million people) in 2015 
            7.9 percent (16.8 million people) in 2017
Past-month use among teens declined slightly from 2015.

Download infographic here.

Marijuana use skyrockets in the 70s,
falls to its lowest levels in the 90s,
and gradually rises again
Past-month marijuana use peaked in 1979.
  •  Adolescents 14.2 percent
  •  Young adults 35.6 percent
  • Adults 19.7 percent 
It fell to its lowest levels in 1992 (1999 for adults).
  • Adolescents 3.4 percent
  • Young adults 10.9 percent
  • Adults 5.4 percent 
Since then, marijuana use has gradually increased to 2017.
  • Adolescents 6.5 percent – nearly double 1992 use
  • Young adults 22.1 percent – more than double 1992 use
  • Adults 14.8 percent – nearly triple 1999 use
The national parent movement for drug-free youth is credited with the dramatic drop in marijuana use between 1979 and 1992. The legalization movement received a considerable boost in funding in the early 90s, which it used to finance ballot initiatives in vulnerable states. In 1996, it persuaded California to become the first state to legalize marijuana for medical use. Some 30 states followed, and nine of those have fully legalizing the drug since 2012.

Download infographic here
Pregnant women’s past-month marijuana use more than doubles in just two years.
So does their daily use!
Marijuana use among pregnant women more than doubles.
  • 78,000 in 2015
  • 161,000 in 2017 
Daily or near daily use also more than doubles.
  • 28,000 in 2015
  • 69,000 in 2017 
This concerns health officials. Use during pregnancy has been associated with
  • fetal growth restriction
  • stillbirth and preterm birth 
Use during pregnancy may also cause problems with neurological development, resulting in
  • hyperactivity and
  • poor cognitive function in childhood 
Download infographic here.
Reduce past-year and daily/near daily
marijuana use to reduce opioid misuse.
SAMHSA conducted a special analysis of its data from the 2017 National Survey on Drug Use and Health. It shows the clear link between marijuana and opioid abuse.  

In the past year:
  • 21.8 million used no marijuana. Of those, 1.6% (343 thousand adolescents) misused opioids.
  • 3.1 million used marijuana. Of those, 13.8% (426 thousand adolescents) misused opioids.
  • 250 thousand used marijuana daily/near daily. Of those, 31.8% (79 thousand adolescents) misused opioids. 
Young Adults
In the past year:
  • 22.4 million used no marijuana. Of those, 3.3% (745 thousand young adults) misused opioids.
  • 12 million used marijuana. Of those, 14.6% (1.7 million young adults) misused opioids.
  • 2.6 million used marijuana daily/near daily. Of those, 24.1% (630 thousand young adults) misused opioids. 
In the past year:
  • 187 million adults used no marijuana. Of those, 2.6% (4.8 million adults) misused opioids.
  • 26 million adults used marijuana. Of those, 12.9% (3.3 million adults) misused opioids.
  • 5.3 million adults used marijuana daily/near daily. Of those, 18.6% (975 thousand adults) misused opioids 
Download infographic here.
Coca-Cola is in talks to make
marijuana-infused drinks
Canada is set to legalize marijuana nationwide in October. And Coca-Cola, the Atlanta-based soft drink giant, is talking with a Canadian marijuana growing company, Aurora, about a joint venture to create beverages with infused marijuana.
Soon after the news broke Monday, Coca-Cola issued a statement pretending that CBD is not related to marijuana from which it comes and which is illegal under US federal law:
“We have no interest in marijuana or cannabis. Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. The space is evolving quickly. No decisions have been made at this time.”
Other beverage companies are already linking with pot industry companies to make pot-infused drinks, according to Axois:
  • “Constellation Brands, an American beer, wine and spirits company, is pouring $4 billion into cannabis company Canopy Growth.
  • “Heineken’s subsidiary Lagunitas is out with weed-infused sparkling water — a collaboration with AbsoluteXtracts, another cannabis company.
  • “Big-time brewer MolsonCoors is linking up with The Hydropothecary Corporation to roll out cannabis-infused drinks.
  • “Diageo, the drinks giant behind Smirnoff vodka and Guinness beer, may collaborate with a Canadian cannabis company.”
Read New York Post story here. Read Coca-Cola statement here. Read Axios story here.
Real vs fake marijuana medicines

The CBD Coca-Cola may pursue as a “wellness” product is the same CBD that has emerged from legalizing marijuana for medical use in some 30 states in the US. Hundreds of CBD products are now on the market even though all are illegal under federal law.
The only CBD product that qualifies as medicine is Epidiolex, which is purified, and which FDA approved in June to treat epilepsy. It will be available later this fall. Syndros, liquid THC, also approved by FDA as safe and effective, is available now, as are two other medicines (not shown here), Marinol and Cesamet, both THC capsules.
No other marijuana products have been approved as safe or effective by FDA and can contain the hazards listed below.
Download National Families in Action’s infographic here and here.

Disclosure: The Marijuana Report’s Executive Editor, Sue Rusche, holds stock in Epidiolex.

2 million US teens are vaping marijuana
Researchers at the Centers for Disease Control and Prevention (CDC) surveyed some 20,000 students in grades 6-12 about their marijuana use in e-cigarettes. They found that nearly 1 in 11, or 2.1 million middle and high school students used marijuana in e-cigarette devices.
In legal states people can buy cartridges of high-potency cannabis oil that fit into many e-cigarette devices. The popular Juul does not make marijuana pods, but users can refill Juul’s nicotine cartridges with cannabis oil.
Health officials are concerned “because cannabis use among youth can adversely affect learning and memory and may impair later academic achievement and education,” said lead researcher Katrina Trivers.
Read Seattle Times article here. Read JAMA Pediatrics study here.

The Marijuana Report is a weekly e-newsletter published by National Families in Action in partnership with SAM (Smart Approaches to Marijuana).

Visit National Families in Action's website, The Marijuana Report.Org, to learn more about the marijuana story unfolding across the nation.

Subscribe to The Marijuana Report e-newsletter.

The Marijuana Report Staff
Executive Editor—Sue Rusche
Editor—Nicole Carter
IT Consultant—Lee Clontz
Social Media Coordinator—Margarita Eberline
We are grateful to our Board of Directors and Senior Adviser for their support of National Families in Action, which produces The Marijuana Report website and e-newsletter.
National Families in Action
Board of Directors

William F. Carter, Chairman of the Board & Realtor 
Berkshire Hathaway HomeServices – Georgia Properties, Atlanta.
Sue Rusche, President and CEO, Atlanta.
Richard L. Brown, Secretary & Attorney &
 Executive Director, Sudden Cardiac Arrest Association, Lakewood Ranch, Florida.
Marcie Beskind, Treasurer & Chief Financial Officer/Chief Administrative Officer,
Jewish Federation of Greater Atlanta.
Jeannine F. Adams, Director & President and CEO
J. Addams & Partners, Atlanta.
William H. Avery, Director & Partner (Ret.)
Alston & Bird, LLP, Atlanta.
Margarita Eberline, Director & Strategy Director
360 Marketing Plus, Atlanta.
Robert Margolis, PhD, Director & Founder 
Caron Solutions Intensive Outpatient Program, Roswell, Georgia.
Senior Adviser
Kent “Oz” Nelson, Chairman and CEO (Ret.)
United Parcel Service, Atlanta.
National Families
National Families
National Families
The MJ Report
The MJ Report
The MJ Report
Copyright © 2018 National Families in Action, All rights reserved.

unsubscribe from this list    update subscription preferences